Exchange: NASDAQ·Updated 12:02 PM EDT

GELS News

News
all
press releases
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million. Nyxoah (NASDAQ:NYXH) shares increased by 12.58% toread more...
Benzinga
More News
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednesday's regular session. The company's market cap stands at $3.9 million. Gelteq (NASDAQ:GELS) shares increasedread more...
Benzinga
Why Traders Are Piling into These Emerging Healthcare Names as New Catalysts Emerge
Biotechnology and healthcare innovation dominated investor conversations today as multiple companies delivered meaningful corporate, clinical, regulatory, and commercialization updates. From artificial intelligence-powered drug discovery platforms to neuro-oncology, regenerative medicine, wound care technologies, and autoimmune disease therapies, investors focused on companies that could potentially benefit from major industry trends while advancing important milestones of their own. $CUPR, $HYFT, $NTHI, $RGNT, $GELS, $SABS
24-7 Market News
What's Going On With Gelteq Stock Friday?
Micro-cap biotechnology stock Gelteq (GELS) faces erratic price swings, pulling back after a 200% spike. Stock down 33%.read more...
Benzinga
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China
Press Releases
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
Press Releases
Gelteq to Present at Investor Summit Virtual on December 9, 2025
Press Releases
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Press Releases
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform
Press Releases
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound
Press Releases

Advertisement|Remove ads.